Table 3.
Minimum inhibitory concentrations (MIC) of purified or commercially purchased surfactins against selected bacterial strains.
| Target bacteria | MIC | Producing strain | Antibacterial Assay | Reference |
|---|---|---|---|---|
| E. coli AS1.487 | 15.625 μg/ml | Commercially purchased | Microdilution | Huang et al., 2008 |
| P. syringae pv tomato DC3000 | 25 μg/ml | Commercially purchased | Microdilution | Bais et al., 2004 |
| L. monocytogenes 99/287RB6 strains | 125 μg/ml 250 μg/ml 1 mg/ml | B. subtilis C4 B. subtilis G2III B. subtilis M1 | *WDA | Sabate and Audisio, 2013 |
| S. enteritidis | 6.25 μg/ml | Commercially purchased | Microdilution | Huang et al., 2011 |
| V. anguillarum | 1.5 μg/ml | B. amyloliquefaciens M1 | Not specified | Xu et al., 2014 |
| Legionella sp. | 1–4 μg/ml | Commercially purchased | Microdilution | Loiseau et al., 2015 |
| M. pulmonis MpUR1.1 | 25.9 μg/ml | Commercially purchased | Microdilution | Fassi Fehri et al., 2007 |
*WDA: well diffusion assay.
Minimum inhibitory concentrations were determined against L. pneumophila Lens and for the formylated forms of the peptides except for the peptides indicated by *.